Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature

Clin Genitourin Cancer. 2017 Feb;15(1):e99-e103. doi: 10.1016/j.clgc.2016.08.005. Epub 2016 Aug 10.
No abstract available

Keywords: Anti-VEGF agents; Proteinuria; Renal carcinoma; Reversible posterior leukoencephalopathy syndrome; Tyrosine kinase inhibitors.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Axitinib
  • Carcinoma, Renal Cell / drug therapy*
  • Everolimus / administration & dosage
  • Everolimus / therapeutic use
  • Fatal Outcome
  • Female
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / therapeutic use
  • Indazoles / administration & dosage
  • Indazoles / therapeutic use
  • Kidney Neoplasms / drug therapy*
  • Magnetic Resonance Imaging
  • Middle Aged
  • Nephrotic Syndrome / chemically induced*
  • Posterior Leukoencephalopathy Syndrome / chemically induced*
  • Posterior Leukoencephalopathy Syndrome / diagnostic imaging
  • Pyrimidines / administration & dosage*
  • Pyrimidines / adverse effects
  • Sulfonamides / administration & dosage*
  • Sulfonamides / adverse effects

Substances

  • Imidazoles
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib
  • Everolimus
  • Axitinib